European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCA(A) and the EBSB working groups of the ESCD, and the GEIDAC(C)

DC ElementWertSprache
dc.contributor.authorUter, Wolfgang
dc.contributor.authorWilkinson, S. Mark
dc.contributor.authorAerts, Olivier
dc.contributor.authorBauer, Andrea
dc.contributor.authorBorrego, Leopoldo
dc.contributor.authorBuhl, Timo
dc.contributor.authorCooper, Susan M.
dc.contributor.authorDickel, Heinrich
dc.contributor.authorGallo, Rosella
dc.contributor.authorGimenez-Arnau, Ana M.
dc.contributor.authorJohn, Swen M.
dc.contributor.authorNavarini, Alexander A.
dc.contributor.authorPesonen, Maria
dc.contributor.authorPonyai, Gyorgyi
dc.contributor.authorRustemeyer, Thomas
dc.contributor.authorSchliemann, Sibylle
dc.contributor.authorSchubert, Steffen
dc.contributor.authorSchuttelaar, Marie-Louise A.
dc.contributor.authorValiukeviciene, Skaidra
dc.contributor.authorWagner, Nicola
dc.contributor.authorWeisshaar, Elke
dc.contributor.authorGoncalo, Margarida
dc.contributor.authorESSCA Working Grp
dc.contributor.authorEBS ESCD Working Grp
dc.contributor.authorGEIDAC
dc.date.accessioned2023-02-17T11:36:57Z-
dc.date.available2023-02-17T11:36:57Z-
dc.date.issued2022
dc.identifier.issn0105-1873
dc.identifier.urihttp://osnascholar.ub.uni-osnabrueck.de/handle/unios/65648-
dc.description.abstractBackground In 2019, a number of allergens (haptens), henceforth, ``the audit allergens,'' were considered as potential additions to the European Baseline Series (EBS), namely, sodium metabisulfite, 2-bromo-2-nitropropane-1,3-diol, diazolidinyl urea, imidazolidinyl urea, Compositae mix II (2.5% or 5% pet), linalool hydroperoxides (lin-OOH), limonene hydroperoxides (lim-OOH), benzisothiazolinone (BIT), octylisothiazolinone (OIT), decyl glucoside, and lauryl glucoside; Evernia furfuracea (tree moss), was additionally tested by some departments as well. Objectives To collect further data on patch test reactivity and clinical relevance of the audit allergens in consecutive patients across Europe. Methods Patch test data covering the audit allergens in 2019 and 2020 were collected by those departments of the European Surveillance System on Contact Allergies testing these, as well as further collaborators from the EBS working group of the European Society of Contact Dermatitis (ESCD), and the Spanish Grupo Espanol de Investigacion en Dermatitis de Contacto y Alergia Cutanea. As patch test outcome, reactions between day (D) 3 and D5 were considered. Results Altogether n = 12 403 patients were tested with any of the audit allergen. Positive reactions were most common to lin-OOH 1% pet. (8.74% [95%CI: 8.14-9.37%]), followed by lin-OOH 0.5% pet., and lim-OOH 0.3% pet (5.41% [95% CI: 4.95-5.89%]). Beyond these terpene hydroperoxides, BIT 0.1% pet. was the second most common allergen with 4.72% (95% CI: 4.2-5.28%), followed by sodium metabisulfite 1% pet. (3.75% [95%CI: 3.32-4.23%]) and Compositae mix 5% pet. (2.31% [95% CI: 1.84-2.87%]). For some allergens, clinical relevance was frequently difficult to ascertain. Conclusions Despite many positive patch test reactions, it remains controversial whether lin- and lim-OOH should be tested routinely, while at least the two preservatives BIT and sodium metabisulfite appear suitable. The present results are a basis for further discussion and ultimately decision on their implementation into routine testing among the ESCD members.
dc.description.sponsorshipEADV Grant [PPRC-2018-8]; Spanish Medicines and Health Products Agency (Agencia Espanola de Medicamentos y Productos Sanitarios); Sanofi; GSK; Novartis; Projekt DEAL; This study was funded in part by the EADV Grant PPRC-2018-8. The EBS working group was funded by EADV Grant PPRC-2018-8. The REIDAC project is promoted by the Fundaci~on Piel Sana Academia Espanola de Dermatologia y Venereologia, which has received financial support from the Spanish Medicines and Health Products Agency (Agencia Espanola de Medicamentos y Productos Sanitarios), and from pharmaceutical companies (Sanofi, GSK, and Novartis).; Open access funding enabled and organized by Projekt DEAL.
dc.language.isoen
dc.publisherWILEY
dc.relation.ispartofCONTACT DERMATITIS
dc.subjectAllergy
dc.subjectbaseline series
dc.subjectbenzisothiazolinone
dc.subjectclinical epidemiology
dc.subjectcontact allergy
dc.subjectCONTACT SENSITIZATION
dc.subjectdecyl glucoside
dc.subjectDermatology
dc.subjectLIMONENE
dc.subjectLINALOOL HYDROPEROXIDES
dc.subjectMIX
dc.subjectpatch testing
dc.subjectRRID
dc.subjectSCR_001905
dc.subjectsodium metabisulfite
dc.subjectsurveillance
dc.titleEuropean patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCA(A) and the EBSB working groups of the ESCD, and the GEIDAC(C)
dc.typejournal article
dc.identifier.doi10.1111/cod.14059
dc.identifier.isiISI:000756887100001
dc.description.volume86
dc.description.issue5
dc.description.startpage379
dc.description.endpage389
dc.contributor.orcid0000-0001-7253-3461
dc.contributor.orcid0000-0002-0076-2887
dc.contributor.orcid0000-0002-0199-2756
dc.contributor.orcid0000-0002-4498-3710
dc.contributor.orcid0000-0001-7059-632X
dc.contributor.orcid0000-0001-7580-0684
dc.contributor.researcheridAFP-7298-2022
dc.contributor.researcheridC-5504-2014
dc.identifier.eissn1600-0536
dc.publisher.place111 RIVER ST, HOBOKEN 07030-5774, NJ USA
dcterms.isPartOf.abbreviationContact Dermatitis
dcterms.oaStatusGreen Published
local.import.remainsaffiliations : University of Erlangen Nuremberg; University of Leeds; University of Antwerp; University of Antwerp; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Universidad de Las Palmas de Gran Canaria; University of Gottingen; Oxford University Hospitals NHS Foundation Trust; Ruhr University Bochum; University of Genoa; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University Osnabruck; University of Basel; Finnish Institute of Occupational Health; Semmelweis University; Friedrich Schiller University of Jena; University of Groningen; Lithuanian University of Health Sciences; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra
local.import.remainsearlyaccessdate : FEB 2022
local.import.remainsweb-of-science-index : Science Citation Index Expanded (SCI-EXPANDED)
crisitem.author.deptUniversität Osnabrück-
crisitem.author.orcid0000-0001-5406-9458-
crisitem.author.netidJoSw269-
Zur Kurzanzeige

Seitenaufrufe

1
Letzte Woche
0
Letzter Monat
0
geprüft am 21.05.2024

Google ScholarTM

Prüfen

Altmetric